MOUNJARO 2.5MG (TIRZEPATIDE) INJECTION is an advanced, once-weekly injectable medication used to support blood sugar regulation in adults with type 2 diabetes. It also provides additional benefits for weight management, making it a dual-action treatment with strong clinical backing. Designed to be the starting dose in the MOUNJARO treatment plan, it is ideal for initiating therapy with a GLP-1 and GIP receptor agonist.